Drug Type Therapeutic vaccine, mRNA vaccine |
Synonyms RV 521, RV521 |
Target |
Action inhibitors |
Mechanism KRAS inhibitors(GTPase KRas inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | IND Application | United States | 01 Jul 2025 | |
Lung Cancer | IND Application | United States | 01 Jul 2025 | |
Pancreatic Cancer | IND Application | United States | 01 Jul 2025 | |
Skin Neoplasms | IND Application | United States | 01 Jul 2025 |